Abstract
Transposable elements (TEs) can move within the genome and can have a significant role in cancer development. Shah et al. recently identified that TEs have regulatory potentials and that tumor-specific TE–gene chimeric events that produce new isoforms of proteins could serve as universal cancer biomarkers and targets for cancer immunotherapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
